New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 6, 2012
17:40 EDTAPRIApricus Biosciences CEO Bassam Damaj resigns, CFO Steve Martin named interim CEO
Apricus Biosciences announced that Bassam Damaj, Ph.D., has resigned as a director, president, and CEO of the company and that Steve Martin, senior vice president and CFO, has been appointed interim CEO. The changes are effective immediately. The company also announced that its board has retained an executive recruiting firm to assist in identifying a permanent CEO whose experience is expected to include significant background in commercial operations within the pharmaceutical industry.
News For APRI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 15, 2014
07:35 EDTAPRIApricus Biosciences appoints Barbara Troupin, M.D. as Chief Medical Officer
Subscribe for More Information
December 8, 2014
16:03 EDTAPRIApricus Biosciences files to sell 3.42M share for selling stock holder
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use